FDA inspection
Reese Pharmaceutical Company: FDA inspection ending Dec 9, 2021
FDA inspection 1160702 · No Action Indicated (NAI) · Cleveland, OH
Key facts
| Inspection ID | 1160702 |
|---|---|
| Firm | Reese Pharmaceutical Company |
| FEI number | 1518939 |
| Address | 1617 E. 40th Street |
| City | Cleveland |
| State | OH |
| ZIP | 44106 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Dec 9, 2021 |
| Classification | No Action Indicated (NAI) |
| Project area | Foodborne Biological Hazards |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data